Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Kaplan

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Annali Italiani Di Chirurgia|December 26, 2024
Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast CancerZuhat Urakçı, Muhammet Ali Kaplan, Zeynep Oruç, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.
Future Oncology (London, England)|September 7, 2022
Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapySenar Ebinç, Zeynep Oruç, Yasin Sezgin, et al.
Nuclear Medicine Communications|November 28, 2022
18 F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancerSenar Ebinç, Yunus Güzel, Zeynep Oruç, et al.
Respiration; International Review of Thoracic Diseases|October 1, 2010
A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesotheliomaAbdullah Cetin Tanrikulu, Abdurrahman Abakay, Mehmet Ali Kaplan, et al.
Leukemia Research|February 8, 2021
IPS-3 Validation in 1012 cases with classical hodgkin lymphomaSemra Paydas, Sahin Laçin, Mutlu Doğan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 20, 2014
Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO)Oktay Bozkurt, Halit Karaca, Aydin Ciltas, et al.
Current Problems in Cancer|October 16, 2023
Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative GroupMuhammet Ali Kaplan, Mehmet Ali Nahit Şendur, Ayten Kayı Cangır, et al.
Leukemia Research|June 3, 2021
Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphomaSemra Paydas, Sahin Lacin, Mutlu Dogan, et al.
Journal of Chemotherapy (Florence, Italy)|May 8, 2015
Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?Oktay Bozkurt, Halit Karaca, Ilhan Hacıbekiroglu, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Annali Italiani Di Chirurgia|December 26, 2024
Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast CancerZuhat Urakçı, Muhammet Ali Kaplan, Zeynep Oruç, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.
Future Oncology (London, England)|September 7, 2022
Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapySenar Ebinç, Zeynep Oruç, Yasin Sezgin, et al.
Nuclear Medicine Communications|November 28, 2022
18 F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancerSenar Ebinç, Yunus Güzel, Zeynep Oruç, et al.
Respiration; International Review of Thoracic Diseases|October 1, 2010
A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesotheliomaAbdullah Cetin Tanrikulu, Abdurrahman Abakay, Mehmet Ali Kaplan, et al.
Leukemia Research|February 8, 2021
IPS-3 Validation in 1012 cases with classical hodgkin lymphomaSemra Paydas, Sahin Laçin, Mutlu Doğan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 20, 2014
Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO)Oktay Bozkurt, Halit Karaca, Aydin Ciltas, et al.
Current Problems in Cancer|October 16, 2023
Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative GroupMuhammet Ali Kaplan, Mehmet Ali Nahit Şendur, Ayten Kayı Cangır, et al.
Leukemia Research|June 3, 2021
Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphomaSemra Paydas, Sahin Lacin, Mutlu Dogan, et al.
Journal of Chemotherapy (Florence, Italy)|May 8, 2015
Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?Oktay Bozkurt, Halit Karaca, Ilhan Hacıbekiroglu, et al.
Pageof 15